Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 1.15% is 70% below its 5-year average of 3.90%, near the low end of its 5-year range (-1.50%–19.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 81.21% below its 12-month average of 6.14%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 1.15%.
RETURN ON EQUITY (ROE)
1.15%
RETURN ON EQUITY (ROE) AVG TTM
6.14%
RETURN ON EQUITY (ROE) AVG 3Y
5.43%
RETURN ON EQUITY (ROE) AVG 5Y
3.90%
RETURN ON EQUITY (ROE) AVG 10Y
1.35%
RETURN ON EQUITY (ROE) AVG 15Y
-2.01%
RETURN ON EQUITY (ROE) AVG 20Y
-2.89%
CURRENT VS TTM AVG
-81.21%
CURRENT VS 3Y AVG
-78.75%
CURRENT VS 5Y AVG
-70.42%
CURRENT VS 10Y AVG
-14.78%
CURRENT VS 15Y AVG
+157.36%
CURRENT VS 20Y AVG
+139.94%
SECTOR MEDIAN · HEALTHCARE
-38.25%
median of 444 covered companies
CURRENT VS SECTOR MEDIAN
+103.02%
vs the sector median at left
BioMarin Pharmaceutical Inc.
Market Cap
$11.12B
Return on Equity (ROE)
1.15%
TTM Avg
6.14%
3Y Avg
5.43%
5Y Avg
3.90%
Market Cap
$11.07B
Return on Equity (ROE)
6.85%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
Market Cap
$11.36B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$10.81B
Return on Equity (ROE)
N/A
TTM Avg
77.45%
3Y Avg
86.84%
5Y Avg
112.62%
Market Cap
$11.56B
Return on Equity (ROE)
N/A
TTM Avg
329.18%
3Y Avg
200.63%
5Y Avg
164.66%
Market Cap
$10.66B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$10.35B
Return on Equity (ROE)
11.23%
TTM Avg
7.12%
3Y Avg
6.90%
5Y Avg
7.16%
Market Cap
$12.00B
Return on Equity (ROE)
23.91%
TTM Avg
22.63%
3Y Avg
21.83%
5Y Avg
21.13%
Market Cap
$10.31B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. (BMRN) | $11.12B | 1.15% | 6.14% | 5.43% | 3.90% |
| The Cooper Companies, Inc. (COO)vs › | $11.07B | 6.85% | 4.70% | 4.67% | 11.22% |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 8.63% | 6.23% | 8.78% | 10.01% |
| ImmunityBio, Inc. (IBRX)vs › | $10.81B | N/A | 77.45% | 86.84% | 112.62% |
| DaVita Inc. (DVA)vs › | $11.56B | N/A | 329.18% | 200.63% | 164.66% |
| Universal Health Services, Inc. (UHS)vs › | $10.66B | 20.31% | 18.80% | 15.17% | 15.31% |
| Globus Medical, Inc. (GMED)vs › | $10.35B | 11.23% | 7.12% | 6.90% | 7.16% |
| Encompass Health Corporation (EHC)vs › | $12.00B | 23.91% | 22.63% | 21.83% | 21.13% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.31B | 3.10% | -8.94% | -15.72% | 1.14% |
| Molina Healthcare, Inc. (MOH)vs › | $10.16B | -0.17% | 18.91% | 22.60% | 24.60% |
ROE
1.2%
ROA
0.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 1.15% |
| 2026-03-31 | 4.33% |
| 2025-12-31 | 5.73% |
| 2025-09-30 | 8.59% |
| 2025-06-30 | 10.90% |
| 2025-03-31 | 9.04% |
| 2024-12-31 | 7.54% |
| 2024-09-30 | 5.95% |
| 2024-06-30 | 4.85% |
| 2024-03-31 | 4.05% |
| 2023-12-31 | 3.39% |
| 2023-09-30 | 3.00% |
| 2023-06-30 | 2.09% |
| 2023-03-31 | 1.54% |
| 2022-12-31 | 3.08% |
| 2022-09-30 | 1.84% |
| 2022-06-30 | 1.20% |
| 2022-03-31 | 0.90% |
| 2021-12-31 | -1.50% |
| 2021-09-30 | 0.37% |
| 2021-06-30 | 19.74% |
| 2021-03-31 | 19.10% |
| 2020-12-31 | 20.92% |
| 2020-09-30 | 21.02% |
| 2020-06-30 | 3.78% |
| 2020-03-31 | 3.52% |
| 2019-12-31 | -0.76% |
| 2019-09-30 | -1.38% |
| 2019-06-30 | -3.72% |
| 2019-03-31 | -3.05% |
| 2018-12-31 | -2.60% |
| 2018-09-30 | -4.29% |
| 2018-06-30 | -4.33% |
| 2018-03-31 | -5.16% |
| 2017-12-31 | -4.17% |
| 2017-09-30 | -5.13% |
| 2017-06-30 | -6.05% |
| 2017-03-31 | -19.91% |
| 2016-12-31 | -22.35% |
| 2016-09-30 | -17.80% |
| 2016-06-30 | -27.35% |
| 2016-03-31 | -8.18% |
| 2015-12-31 | -7.16% |
| 2015-09-30 | -13.53% |
| 2015-06-30 | -8.99% |
| 2015-03-31 | -6.74% |
| 2014-12-31 | -8.77% |
| 2014-09-30 | -8.36% |
| 2014-06-30 | -12.77% |
| 2014-03-31 | -11.96% |
| 2013-12-31 | -13.15% |
| 2013-09-30 | -13.11% |
| 2013-06-30 | -9.51% |
| 2013-03-31 | -10.41% |
| 2012-12-31 | -11.26% |
| 2012-09-30 | -8.68% |
| 2012-06-30 | -10.03% |
| 2012-03-31 | -9.51% |
| 2011-12-31 | -6.96% |
| 2011-09-30 | -5.07% |
| 2011-06-30 | 26.72% |
| 2011-03-31 | 27.79% |
| 2010-12-31 | 28.70% |
| 2010-09-30 | 38.03% |
| 2010-06-30 | 3.31% |
| 2010-03-31 | 4.00% |
| 2009-12-31 | -0.15% |
| 2009-09-30 | 6.35% |
| 2009-06-30 | 4.76% |
| 2009-03-31 | 5.84% |
| 2008-12-31 | 11.14% |
| 2008-09-30 | 3.74% |
| 2008-06-30 | 1.26% |
| 2008-03-31 | -2.31% |
| 2007-12-31 | -8.42% |
| 2007-09-30 | -16.48% |
| 2007-06-30 | -18.25% |
| 2007-03-31 | -17.03% |
| 2006-12-31 | -24.22% |
| 2006-09-30 | -27.14% |
| 2006-06-30 | -85.05% |
| 2006-03-31 | -133.88% |
| 2004-09-30 | -923.17% |
| 2004-06-30 | -283.77% |
| 2004-03-31 | -77.01% |
| 2003-12-31 | -64.32% |
| 2003-09-30 | -48.89% |
| 2003-06-30 | -40.15% |
